EFFECT OF L-ARGININE THERAPY ON PLASMA NO2 AND NO3 LEVELS, AND BLOOD PRESSURE IN UREMIC RABBITS

Mohammad Hanif, Khemomal A. Karira, Muhammad Iltaf, Mona Rani, Nusratullah Khan, Haresh Kumar, Shaheena Shaheena, Abdul Wahab

Abstract


Background: Normal kidney function is regulated by Nitric oxide (NO) and Superoxide (O2-) in
the body, and consequently controls blood pressure. Nitric Oxide promotes natriuresis and
diuresis, and therefore results in reduction of blood pressure. The objective of this study was to
determine the effect of L-arginine supplementation on blood pressure, urinary protein, nitrite and
nitrate in addition to blood urea, serum creatinine and creatinine clearance in uremic rabbits.
Methods: This study was carried out in the Department of Biochemistry Basic Medical Sciences
Institute, Jinnah Postgraduate Medical Centre, Karachi. A total of 48 rabbits were included in the
study. Twenty-four of the rabbits on surgical intervention were prepared as uremic and so became
hypertensive as well. Two groups were uremic, one group was given L-arginine and the other was
remained untreated. Systolic and diastolic blood pressure was measured on week 0, week 2, week
4, and week 6, while blood and urine was collected on week 0 and week 6. Results: On
supplementation with L-arginine to uremic rabbits systolic and diastolic blood pressures were
decreased significantly. Nitrite/nitrate and urinary protein were corrected to some extent while
blood urea and serum creatinine were unaffected. Conclusion: L-arginine has a beneficial role as
blood pressure lowering agent in uremic rabbits. It corrects NO2/NO3 plasma level and proteinuria
which is indicator of renal failure.
Keywords: Renal failure, uremia, L-arginine, hypertention, NO2/NO3

Full Text:

PDF

References


Meguid El Nahas A, Bello AK. Chronic kidney disease: the

global challenge. Lancet 2005;365:331–40.

Pecoits Firho R, Lindholm B, Stenvinkel P. The malnutrition,

inflammation and atherosclerosis (MIA) syndrome: the heart

of the matter. Nephrol Dial Transplant 2002;17(Suppl

:28–31.

Ortiz PA, Hong NJ, Wang D, Garvin JL. Gene transfer of

eNOS to the thick ascending limb of eNOS-KO mice restores

the effects of L-arginine on NaCl absorption. Hypertension

;42:674–9.

Brands MW, Bell TD, Gibson B. Nitric oxide may prevent

hypertension early in diabetes by counteracting renal actions

of superoxide. Hypertension 2004;43:57–63.

Napoli C, de Nigris F, Williams-Ignarro F, Pignalosa O, Sica

V, Ignarro LJ. Nitric oxide and atherosclerosis: an update.

Nitric Oxide 2006;15:265–79.

Reyes AA, Karl I, Klahr S. Role of L-arginine in health and

in renal disease. Am J Physiol 1994;267(3 part 2):F331–46.

Brunini TM, Mendes-Ribeiro AC, Ellory JC, Mann GE.

Platelet nitric oxide synthesis in uremia and malnutrition: A

role for L-arginine supplementation in vascular protection?

Cardiovasc Res 2007;73:359–67.

Hayashi T, Juliet PA, Matsui H, Miyazaki A, Fukatsu A,

Funami J, et al. L-Citrulline and L-arginine supplementation

retards the progression of high cholesterol diet induced

atherosclerosis in rabbits. Proc Natl Acad Sci USA

;102:13681–6.

Okubo K, Hayashi K, Wakino S, Matsuda H, Kubota E,

Honda M, et al. Role of Asymmetrical Dimethylarginine in

renal microvascular endothelial dysfunction in chronic renal

failure with hypertension. Hypertens Res 2005;28:181–9.

Carlström M, Brown RD, Edlund J, Sällström J, Larsson E,

Teerlink T, et al. Role of nitric oxide deficiency in the

development of hypertension in hydronephrotic animals. Am

J Physiol Renal Physiol 2008;294:F362–70.

Baylis C. Arginine, arginine analogs and nitric oxide

production in chronic kidney disease. Nat Clin Pract Nephrol

;2:209–20.

Yannick D, D'Amours M, Lebel M, Larivière R.

Supplementation with a low dose of l-arginine reduces blood

pressure and endothelin-1 production in hypertensive uremic

rats. Naprol Dial Transplant 2001;16:746−54.


Refbacks

  • There are currently no refbacks.


Contact Number: +92-992-382571

email: [jamc] [@] [ayubmed.edu.pk]